- Home
- FSV vs ROIV Comparison
FSV vs ROIV Comparison
Compare FSV & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FSV | ROIV |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 20.7B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FSV | ROIV |
|---|---|---|
| Price | $133.78 | $27.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $210.67 | $27.56 |
| AVG Volume (30 Days) | 161.1K | ★ 4.5M |
| Earning Date | 04-23-2026 | 02-06-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,053,000.00 |
| Revenue This Year | $7.45 | N/A |
| Revenue Next Year | $6.77 | $594.84 |
| P/E Ratio | $49.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $136.74 | $8.73 |
| 52 Week High | $205.99 | $30.33 |
Technical Indicators
Market Signals| Indicator | FSV | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 24.69 | 49.52 |
| Support Level | N/A | $26.94 |
| Resistance Level | $158.68 | $27.94 |
| Average True Range (ATR) | 4.32 | 0.96 |
| MACD | -1.29 | -0.38 |
| Stochastic Oscillator | 2.87 | 18.54 |
Price Performance
Historical ComparisonAbout FSV FirstService Corporation
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.